Lazard Asset Management
TNDM icon

Lazard Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Lazard Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,911
Closed -$54K – 2313
2025
Q2 		$54K Buy
2,911
+260
+10% +$5.15K ﹤0.01% 1998
2025
Q1 		$50K Buy
+2,651
New +$77.6K ﹤0.01% 1993
2023
Q1 		– Sell
-406
Closed -$18K – 2552
2022
Q4 		$18K Sell
406
-904
-69% -$40.9K ﹤0.01% 2144
2022
Q3 		$62K Sell
1,310
-1,083
-45% -$59.4K ﹤0.01% 1704
2022
Q2 		$141K Sell
2,393
-223
-9% -$18.3K ﹤0.01% 1381
2022
Q1 		$304K Buy
2,616
+1,663
+175% +$194K ﹤0.01% 1190
2021
Q4 		$143K Buy
953
+62
+7% +$8.37K ﹤0.01% 1344
2021
Q3 		$106K Sell
891
-32
-3% -$3.53K ﹤0.01% 1403
2021
Q2 		$89K Buy
923
+48
+5% +$4.28K ﹤0.01% 1386
2021
Q1 		$77K Buy
+875
New +$81.3K ﹤0.01% 1271
2020
Q3 		– Sell
-750
Closed -$74K – 1742
2020
Q2 		$74K Sell
750
-632
-46% -$50.4K ﹤0.01% 1098
2020
Q1 		$88K Buy
1,382
+505
+58% +$35.4K ﹤0.01% 1025
2019
Q4 		$52K Buy
877
+636
+264% +$39.2K ﹤0.01% 1048
2019
Q3 		$14K Buy
+241
New +$15.4K ﹤0.01% 1195

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management's TNDM Position: Q3 2025 in Review

Lazard Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 2,911 shares — an estimated $54K sold.

Lazard Asset Management first reported a position in TNDM in Q3 2019 and held it in 14 quarters. The position peaked at $304K in Q1 2022. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Lazard Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 2,911 Tandem Diabetes Care shares in Q3 2025, an estimated $54K.
  • Lazard Asset Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 14 quarters.
  • Lazard Asset Management's Tandem Diabetes Care position peaked at $304K in Q1 2022.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.